Department of Internal Medicine at University of Genoa, Italy.
Dr. Diego Bagnasco is an Assistant Professor at the Department of Internal Medicine and Medical Specialties, School of Medical and Pharmaceutical Sciences, University of Genoa, Italy. He specializes in allergy and respiratory diseases, focusing on asthma and biologic treatments. Dr. Bagnasco has contributed significantly to research on severe asthma, allergen immunotherapy, and personalized medicine. He has worked at the Azienda Ospedaliera Universitaria San Martino (IRCCS) in Genoa and has published extensively in peer-reviewed journals. His work aims to improve treatment strategies for respiratory conditions through innovative and targeted therapies.
Professional profile:
Google Scholar
Education & Experience 🎓💼
✅ Doctorate: Ph.D. in Medical Sciences, University of Genoa
✅ Assistant Professor: University of Genoa, Department of Internal Medicine and Medical Specialties
✅ Research Assistant: Azienda Ospedaliera Universitaria San Martino (IRCCS), Genoa
✅ Expertise: Severe asthma, biologic therapies, allergen immunotherapy, personalized medicine
Professional Development 🚀📚
Dr. Bagnasco actively contributes to advancements in allergy and respiratory diseases through research, teaching, and clinical practice. He collaborates with leading institutions and researchers in the field to explore innovative approaches to asthma treatment. His studies focus on the long-term effects of biologics and immunotherapy, aiming to enhance personalized treatment options for patients. As a key figure in respiratory medicine, he participates in international conferences, peer reviews articles for top-tier journals, and mentors students in medical sciences. His dedication to translational research bridges the gap between clinical practice and scientific discovery.
Research Focus 🔬🩺
Dr. Bagnasco’s research revolves around severe asthma, allergen immunotherapy, and biologic treatments. He investigates how biologics, such as mepolizumab, affect asthma patients and the risks associated with discontinuation. His work also explores personalized treatment strategies for respiratory diseases, with a particular emphasis on precision medicine. His contributions aim to improve patient outcomes by identifying biomarkers for targeted therapies, reducing asthma exacerbations, and optimizing long-term management plans for individuals with severe respiratory conditions.
Awards & Honors 🏆🎖
✔️ Recognized expert in allergy and respiratory diseases
✔️ Published in high-impact medical journals
✔️ Contributor to international conferences on asthma and immunotherapy
✔️ Reviewer and editorial board member for allergy and respiratory journals
✔️ Collaborator in major research projects on biologic treatments
Publication Top Notes
- A critical evaluation of anti-IL-13 and anti-IL-4 strategies in severe asthma – D Bagnasco, M Ferrando, G Varricchi, G Passalacqua, GW Canonica, 277 citations, 2016.
- Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs – G Varricchi, D Bagnasco, F Borriello, E Heffler, GW Canonica, 245 citations, 2016.
- Type 2 immunity in asthma – M Caminati, DL Pham, D Bagnasco, GW Canonica, 193 citations, 2018.
- Minimal clinically important difference for asthma endpoints: an expert consensus report – M Bonini, M Di Paolo, D Bagnasco, I Baiardini, F Braido, M Caminati, …, 154 citations, 2020.
- Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19 – J Bousquet, JM Anto, W Czarlewski, T Haahtela, SC Fonseca, G Iaccarino, …, 147 citations, 2021.